✦ LIBER ✦

The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder

✍ Scribed by Rothschild, Anthony J.; Raskin, Joel; Wang, Chia-Ning; Marangell, Lauren B.; Fava, Maurizio

Book ID: 122261182
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 602 KB
Volume: 55
Category: Article
ISSN: 1532-8384
DOI: 10.1016/j.comppsych.2013.08.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Longitudinal relationship between depres

Longitudinal relationship between depressive symptoms and work outcomes in clinically treated patients with long-term sickness absence related to major depressive disorder

✍ Hees, Hiske L.; Koeter, Maarten W.J.; Schene, Aart H. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 253 KB

The relationship between changes in depr

The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes

✍ Wayne J. Katon; Joan E. Russo; Susan R. Heckbert; Elizabeth H.B. Lin; Paul Ciech 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

## Abstract ## Background This longitudinal study of patients with diabetes examined the relationship between changes in depressive symptoms and changes in diabetes self‐care behaviors over 5 years. ## Design, Patients and Measurements A total of 2759 patients with diabetes enrolled in a large H

The Moderating Role of Locus of Control

The Moderating Role of Locus of Control on the Relationship Between Anger and Depression in Patients With Major Depression Disorder

✍ Atefe Abdolmanafi; Mohamad Ali Besharat; Hojatollah Farahani; Mohamad Reza Khoda 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 402 KB

The Moderating Role of Locus of Control

The Moderating Role of Locus of Control on the Relationship Between Anger Rumination and Depression in Patients with Major Depression Disorder

✍ Atefe Abdolmanafi; Mohamad Ali Besharat; Hojatollah Farahani; Mohamad Reza Khoda 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 379 KB

Assessment of depressive symptoms and fu

Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol

✍ Tina Marie Myers Oakes; Adam L. Myers; Lauren B. Marangell; Jonna Ahl; Apurva Pr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 3 views

Objective Return of functional ability is a central goal in the treatment of major depressive disorder. We conducted two trials with the same protocol that was designed to assess functioning after 8 Weeks of treatment with duloxetine. Methods The a priori primary outcome was improvement in the Hamil

Association between plasma paroxetine co

Association between plasma paroxetine concentration and changes in plasma brain-derived neurotrophic factor levels in patients with major depressive disorder

✍ Norio Yasui-Furukori; Shoko Tsuchimine; Taku Nakagami; Akira Fujii; Yasushi Sato 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Recent studies have implicated brain-derived neurotrophic factor (BDNF) in the pathophysiology of depression and in the activities of antidepressant drugs. Serum BDNF levels are lower in depressed patients and increase in response to antidepressant medications; however, no studies have examined the